Drug Trial News

RSS

Bilateral cochlear implants: A case when two are definitely superior to one

A study of cochlear implant patients seen by Indiana University School of Medicine physicians is the first research to show evidence that cochlear implants in both ears significantly improves quality of life in patients with profound hearing loss and that the cost of the second implant is offset by its benefits.

30 May 2008

Lack of dental care may have life-threatening implications

New research from the University of Bristol shows that admissions for the surgical treatment of dental abscess have doubled in the last ten years despite the fact that these serious infections are preventable with regular dental care.

29 May 2008

University of Pennsylvania researcher to launch drug trial in Chinese province among IDUs

David Metzger, director of the HIV/AIDS Prevention Research Division at the University of Pennsylvania, and colleagues plan to launch a trial in China among injection drug users to determine if a drug that reduces the craving for heroin also can reduce the spread of HIV through the sharing of contaminated needles, the Philadelphia Inquirer reports.

28 May 2008

New multi-million pound study to find the cause of Type 1 diabetes

Juvenile Diabetes Research Foundation (JDRF) has awarded more than £3 million to fund a research centre that will investigate the causes of Type 1 diabetes - a condition that results from an immune attack on the body's insulin producing cells. The study, known as the JDRF Centre for Diabetes Genes, Autoimmunity and Prevention (D-GAP), aims to understand how and why Type 1 diabetes occurs, knowledge that may help develop future therapies with the aim of preventing the condition.

28 May 2008

First patient enrolled in phase III study of Bevacizumab and Trastuzumab in early breast cancer

A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.

27 May 2008

Gum disease an indicator of increased cancer risk

British scientists say gum disease, both in smokers and non-smokers, may be a warning sign of an increased risk of cancer.

27 May 2008

Antipsychotic drugs dangerous for the elderly

A Canadian study has found that prescribing antipsychotic drugs for elderly people may be dangerous.

27 May 2008

Alpha1-antitrypsin deficiency associated with increased risk of lung cancer

Carriers of a common genetic disorder previously linked to lung disease may have a 70-percent to 100-percent increased risk of lung cancer, according to a report in the May 26 issue of Archives of Internal Medicine

26 May 2008

Flavanols in cocoa improve artery function, help relieve stress on heart

For people with diabetes, sipping a mug of steaming, flavorful cocoa may seem a guilty pleasure. But new research suggests that indulging a craving for cocoa can actually help blood vessels to function better and might soon be considered part of a healthy diet for the prevention of cardiovascular disease.

26 May 2008

Common gene disorder doubles risk of lung cancer, even among nonsmokers

Mayo Clinic researchers have found that carrying a common genetic disorder doubles the risk of developing lung cancer in smokers and nonsmokers.

26 May 2008

Bivalirudin improves net clinical outcomes and increases survival in heart attack patients

A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).

26 May 2008

Why do some heavy drinkers develop mouth and throat cancers while others do not?

A study by researchers in Europe has revealed why some heavy drinkers develop mouth and throat cancers while others do not and also why some people get drunk quickly.

26 May 2008

Good news for diabetics

A study has found that a short course of intensive insulin treatment may delay the progression of the disease in people newly diagnosed with type 2 diabetes

25 May 2008

Higher-risk people are shunning colon cancer screens

It is difficult to make colon cancer screening effective, according to a follow-up study conducted by the Swedish medical university Karolinska Institutet of a screening programme from 1999. Many of the people who would probably have benefited most from the survey opted not to take part.

25 May 2008

HIV patients suffer more from osteoporosis

Following the introduction of HAART (Highly Active Antiretroviral Therapy), the survival and quality of life for people infected with the human immunodeficiency virus (HIV-1) have increased in the resource-rich countries. However, with this improved prognosis an increase in long term negative disorders has been observed, namely osteoporosis (the gradual loss of bone mass).

25 May 2008

RTOG study likely treatment option for brain tumor patients like Sen. Kennedy

A Radiation Therapy Oncology Group (RTOG) study which seeks to establish whether high-doses of the chemotherapy drug temozolomide after radiotherapy can improve outcome for patients with newly diagnosed malignant glioma is a possible consideration for Sen. Edward Kennedy (D-Mass.) and other patients with this type of brain tumor.

22 May 2008

Anti-rejection drug sirolimus may increase risk of diabetes after kidney transplant

For patients undergoing kidney transplantation, treatment with the anti-rejection drug sirolimus may lead to an increased risk of diabetes, reports a study in the July Journal of the American Society of Nephrology (JASN).

22 May 2008

Experimental drug blocks prostate cancer in animal study

An experimental drug has blocked the progression of prostate cancer in an animal model with an aggressive form of the disease, new research shows.

22 May 2008

Two Penn studies show drug-eluting stents outperform bare metal stents

The more than ten million Americans who've received drug-eluting stents to open their blocked coronary arteries have a bright future, according to new research from the University of Pennsylvania School of Medicine.

22 May 2008

Smoke-free laws are protecting all workers according to new study

A new study published today by the U.S. Centers for Disease Control and Prevention underscores the powerful momentum across the country to pass strong smoke-free workplace laws that protect all workers and the public from the serious health hazards of secondhand smoke.

22 May 2008